GenSight Biologics secures cash, advances regulatory and manufacturing plans for LUMEVOQ
PARIS, FRANCE: GenSight Biologics, a biopharma company that develops gene therapies for eye and brain disorders, announced today that it has secured enough cash to...
GenSight raises €30mn in an oversubscribed private placement in EU and US
PARIS: GenSight Biologics has announced that the company has successfully raised €30 million in an oversubscribed private placement with European and US institutional investors. The...